Blog

Breastcancer.org Covers the 2014 San Antonio Breast Cancer Symposium

We’re proud to bring you our coverage of the 2014 San Antonio Breast Cancer Symposium! Below, please find our audio and video interviews as well as written summaries of research presented December 9-13, 2014 in San Antonio, TX.

Podcast coverage:

2014 San Antonio Breast Cancer Symposium Research Highlights

Running time: 16:01

Listen to Senior Editor Jamie DePolo talk with Brian Wojciechowski, M.D., Breastcancer.org medical adviser, …

Sex Matters: Managing Your Mojo, Part 1

In last month’s blog posting, we saw that the U.S. Food and Drug Administration has considered lowered sexual interest or lowered libido an unmet medical need. Many women who have breast cancer feel like their libido has vanished — gone and doomed never to return.

With the recent newly published Diagnostic and Statistical Manual V (DSMV), Hypoactive Sexual Desire Disorder and Sexual Arousal Disorder …

Thriving Emotionally During the Holidays

The holidays bring a mix of happiness and stress, hopefulness and memories, and mixed emotions for many. All of these feelings can combine in an especially bittersweet blend for women experiencing breast cancer. Coping with the real challenges as well as the joys of shopping, cooking, family gatherings, and other celebrations can be an emotional roller coaster when you are dealing with your own illness.…

I Am Strong, I Am Not

I describe my year of cancer as sleeping with an enemy, unrelenting and omnipresent. I couldn’t shake its presence, even in those brief moments of relaxation. It was always worse at night. My husband was asleep and my daughter at college, and in the darkness, the house almost silent, except for the usual creaks and groans, nothing could be denied. To the world, I presented …

Sex Matters: The Recent FDA Seminar on Female Sexual Dysfunction

I decided to delay our jump into the topic of libido since I want to update you on a very important meeting that recently took place at the Food and Drug Administration (FDA) in Washington, DC in late October. On the 27^th and 28^th, the FDA convened a 2-day seminar to discuss the issues of the unmet medical need for treatment for …